Targeting intestinal inflammation using locked nucleic acids delivered via lipid nanoparticles
Abstract Locked nucleic acids are a third-generation antisense oligonucleotides with high binding affinity. A major limitation is the high dosages they require to achieve efficacy which may induce unwanted adverse effects. Here, we report the use of Lipid-based nanoparticles to deliver locked nuclei...
| Published in: | Nature Communications |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Online Access: | https://doi.org/10.1038/s41467-025-63037-6 |
